SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anika Therapeutics, Inc. – ‘PREC14A’ on 3/27/23 re: Anika Therapeutics, Inc. – ‘EX-101.LAB’

On:  Monday, 3/27/23, at 8:48am ET   ·   Accession #:  1193125-23-79887   ·   File #:  1-14027

1 Reference:  By:  SEC – ‘UPLOAD’ on 4/4/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/23  Anika Therapeutics, Inc.          PREC14A               12:7.2M Anika Therapeutics, Inc.          Donnelley … Solutions/FA

Preliminary Proxy Statement – Contested Solicitation   —   Schedule 14A

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: PREC14A     Preliminary Proxy Statement - Contested             HTML   1.25M 
                Solicitation                                                     
 6: R1          Cover                                               HTML     16K 
 7: R2          Pay vs Performance Disclosure                       HTML    258K 
10: XML         IDEA XML File -- Filing Summary                      XML     20K 
 8: XML         XBRL Instance -- d480900dprec14a_htm                 XML    348K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX     16K 
 3: EX-101.DEF  XBRL Definitions -- anik-20221231_def                XML     20K 
 4: EX-101.LAB  XBRL Labels -- anik-20221231_lab                     XML     24K 
 5: EX-101.PRE  XBRL Presentations -- anik-20221231_pre              XML     18K 
 2: EX-101.SCH  XBRL Schema -- anik-20221231                         XSD     18K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks              101±   126K 
12: ZIP         XBRL Zipped Folder -- 0001193125-23-079887-xbrl      Zip   2.29M

‘EX-101.LAB’   —   XBRL Labels — anik-20221231_lab

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 27-March-2023 [03:50:10] {PM} -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_AdjustmentsRelatedToEquityAwardsMember" xlink:label="loc_anik_AdjustmentsRelatedToEquityAwardsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_AdjustmentsRelatedToEquityAwardsMember" xml:lang="en-US"> Adjustments Related to Equity Awards [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_AdjustmentsRelatedToEquityAwardsMember" xlink:to="lab_anik_AdjustmentsRelatedToEquityAwardsMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_GrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="loc_anik_GrantFairValueOfEquityAwardsMadeDuringYearMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_GrantFairValueOfEquityAwardsMadeDuringYearMember" xml:lang="en-US"> Grant Fair Value of Equity Awards Made During Year [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_GrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:to="lab_anik_GrantFairValueOfEquityAwardsMadeDuringYearMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_YearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="loc_anik_YearEndFairValueOfEquityAwardsMadeDuringYearMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_YearEndFairValueOfEquityAwardsMadeDuringYearMember" xml:lang="en-US"> Year End Fair Value of Equity Awards Made During Year [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_YearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:to="lab_anik_YearEndFairValueOfEquityAwardsMadeDuringYearMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="loc_anik_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xml:lang="en-US"> Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:to="lab_anik_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:label="loc_anik_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xml:lang="en-US"> Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:to="lab_anik_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember" xlink:label="loc_anik_FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember" xml:lang="en-US"> Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember" xlink:to="lab_anik_FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember" xlink:label="loc_anik_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember" xml:lang="en-US"> Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember" xlink:to="lab_anik_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_BlanchardMember" xlink:label="loc_anik_BlanchardMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_BlanchardMember" xml:lang="en-US"> Dr. Blanchard [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_BlanchardMember" xlink:to="lab_anik_BlanchardMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_DarlingMember" xlink:label="loc_anik_DarlingMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_anik_DarlingMember" xml:lang="en-US"> Mr. Darling [Member] </label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_anik_DarlingMember" xlink:to="lab_anik_DarlingMember"/>
</labelLink>
</linkbase>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/04/23  SEC                               UPLOAD8/04/23    2:43K  Anika Therapeutics, Inc.
↑Top
Filing Submission 0001193125-23-079887   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 4:39:30.1pm ET